Condition

Colorectal Cancer Metastatic

ClinicalTrials.gov condition label

Clinical trials12
Recruiting3
Common interventions19
Lead sponsors shown12

Clinical trials

12 shown
A Phase II Clinical Study of Multimodal Ablation Combined With Systemic Drug Therapy for Advanced Solid Tumors.NCT06889610 · 2026-03-30
RECRUITING
In Vivo Lung Perfusion (IVLP) for Colorectal Cancer Metastatic to LungNCT05611034 · 2023-02-06
RECRUITING
PRELUDE-1 (Prospective Evaluation of Radiotherapy-induced Biologic Effects in Colorectal Cancer Oligometastatic Patients with LUng-limited Disease: Evolution of Cancer Genetics and Regulatory Immune Cells)NCT04854213 · 2021-10-06
RECRUITING
First-in-Human Study of ATX-559, an Oral Inhibitor of DHX9, in Patients With Advanced or Metastatic Solid Tumors, and Molecularly Defined CancersNCT06625515 · 2024-10-11
TERMINATED
Colorectal Pulmonary Metastases: Pulmonary Metastasectomy Versus Stereotactic Ablative RadiotherapyNCT05808790 · 2024-01-01
NOT_YET_RECRUITING
XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies.NCT06792435 · 2023-07-27
ACTIVE_NOT_RECRUITING
A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 ExpressionNCT05736731 · 2023-04-28
ACTIVE_NOT_RECRUITING
A Trial of Camrelizumab Combined With Microwave Ablation and Chemotherapy in the Treatment of Colorectal Cancer Liver Metastasis/Pulmonary MetastasisNCT04888806 · 2021-06-01
UNKNOWN
Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.NCT03983954 · 2019-10-10
ACTIVE_NOT_RECRUITING
A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed TumorsNCT03775850 · 2018-12-19
COMPLETED
The Oncopanel Pilot (TOP) StudyNCT02171286 · 2014-10-01
COMPLETED
The Jules Bordet Institute Molecular Profiling Program Feasibility TrialNCT01932489 · 2013-12-01
COMPLETED

Common interventions

A2B530BIOLOGICAL1ablationPROCEDURE1ATX-559DRUG1Biopsy of a metastatic lesion.PROCEDURE1CamrelizumabDRUG1chemotherapyDRUG1EDP1503BIOLOGICAL1Minimally invasive pulmonary metastasectomyPROCEDURE1MTT(Multimodal Tumor Thermal Therapy System)- Colorectal CancerCOMBINATION_PRODUCT1MTT(Multimodal Tumor Thermal Therapy System)- MelanomaCOMBINATION_PRODUCT1MTT(Multimodal Tumor Thermal Therapy System)- Triple-Negative Breast CancerCOMBINATION_PRODUCT1Naptumomab estafenatox and durvalumabCOMBINATION_PRODUCT1Obinutuzumab, naptumomab estafenatox and durvalumabCOMBINATION_PRODUCT1OxaliplatinDRUG1PembrolizumabBIOLOGICAL1Stereotactic ablative radiotherapyRADIATION1Stereotactic Body Radiation Therapy (SBRT)DEVICE1XNW27011DRUG1xT-Onco with HLA-LOH AssayDIAGNOSTIC_TEST1

Trial status mix

ACTIVE_NOT_RECRUITING3
COMPLETED3
RECRUITING3
NOT_YET_RECRUITING1
TERMINATED1
UNKNOWN1

Phase mix

PHASE16
PHASE24
NA3

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.